What Results to Expect: Regulates Blood Sugar levels: GLP-1 agonists regulate blood sugar by increasing insulin secretion and reducing gluconeogenesis (creation of sugars by the body)
A lot of people dont bring up diarrhea on GLP-1 medications because they feel its awkward or think its just part of it. I make a point to ask, because bowel changes can signal dehydration, food triggers, or that the dose is moving too fast
Novo Nordisk Dominating the rapidly expanding obesity and diabetes treatment market
A big reason for this is that its common to gain back some of the weight youve lost when you stop taking the prescribed medication
In this blog post we examine the overall market context from the top-selling drugs of 2025 H1 to the surge of dealmaking in obesity therapeutics and then drill into why Eli Lilly, with its GLP-1 pipeline and commercialization strategy, has emerged as the biggest beneficiary of this trend
VK2809, oral thyroid hormone receptor beta agonist for MASH